Selecting formulation early cuts time to market, says Formac
Formac Pharmaceuticals and WR Grace say their silica platform can improve the formulation selection process for poorly soluble APIs (active pharmaceutical ingredients).
Archives for March 21, 2012
Advantar Labs moving to new site to build CRO relationships
Advantar Laboratories is moving to a bigger facility in San Diego this week to expand its relationships with CROs.
Synergy hopes to corner EU sterilisation market through Leoni Stduer Hard takeover
Synergy Health has completed a $62.9m (€47.6m) takeover of Swiss sterilisation firm Leoni Studer Hard from Leoni Group in a bid to further its reach in Europe.
Icon seeks longer partnerships to avoid three-year deal probs
Icon wants longer contracts with partners after finding three-year deals can be “a little problematic”, its president said.
Teva eyes delivery devices to gain edge in biosimilar sector
Teva will try to use different delivery devices for biosimilars to gain an edge over innovator products, its North American CEO said.
Latest developments in biomanufacturing tech
March has already been a busy month for the biomanufacturing technology sector and here is in-Pharmatechnologist.com’s round-up of some of the developments so far.
Indian dominance of CEP suspension list reflects inspection policy says EDQM
Indian API manufacturers may dominate the list of companies that have had CEPs suspended this year, but that may say more about inspection policies than it does about standards outside Europe.